Pharmaceutical Technology
May 02, 2010
Washington Report
34
5
Manufacturers will pay new fees but anticipate expanded drug use and safeguards for innovation.
May 02, 2010
Statistical Solutions
34
5
A method for determining sample size is finally getting some respect.
May 02, 2010
Industry Leaders: Q&A
34
5
Lorensen discusses client demands and industry trends.
May 02, 2010
From The Editor
34
5
FDA wants industry to talk to them about the science underlying process innovations-really.
May 02, 2010
Peer-Reviewed Research
34
5
In this case study of amines, the authors discuss several parameters to be considered in developing a headspace GC method.
May 02, 2010
Outsourcing Outlook
34
5
Eli Lilly faces up to the new realities of the bio/pharmaceutical industry through outsourcing.
May 02, 2010
Ingredients Insider
34
5
Chemocatalysis and biocatalysis are important elements of an effective strategy for improving yield and stereoselectivty.
May 02, 2010
Peer-Reviewed Research
34
5
The authors demonstrate that sustained-release delivery can help avoid the risk of sudden higher-blood concentration of a drug to avoid toxicity.
May 02, 2010
News
34
5
The growth of Brazil's generic-drug market is on a fast track, but what are the projections for the sector's future?
May 02, 2010
Online Exclusives
34
5
A book helps statistics novices prepare to comply with the US Food and Drug Administration's draft guidance on process validation.
May 02, 2010
In the Spotlight
34
5
Editors' Picks of pharmaceutical science and technology innovations
May 02, 2010
PharmTech Talk
34
5
Agreement on standards for excipient qualification, development, and fair pricing is underway.
May 02, 2010
Special Report
34
5
A modular approach to biopharmaceutical production could bring process flexibility, and contract manufacturing organizations are beginning to take notice.
May 02, 2010
Agent-in Place
34
5
When vessels, seals, and cooling units go haywire, operators must get in the mix.